Walgreens Boots Alliance (WBA) Projected to Post Quarterly Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) will likely be announcing its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.66 EPS. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Down 0.3 %

NASDAQ WBA opened at $11.12 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance has a 52 week low of $8.08 and a 52 week high of $22.05. The stock has a market capitalization of $9.61 billion, a P/E ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The stock has a fifty day moving average of $10.92 and a 200-day moving average of $9.87.

Wall Street Analyst Weigh In

WBA has been the topic of a number of research reports. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, March 18th. They issued a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Evercore ISI raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Finally, Royal Bank of Canada upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.